Saikosaponin A of Bupleurum chinense (Chaihu) elevates bone morphogenetic protein 4 (BMP-4) during hepatic stellate cell activation

Phytomedicine. 2013 Nov 15;20(14):1330-5. doi: 10.1016/j.phymed.2013.07.010. Epub 2013 Aug 19.

Abstract

Background: Saikosaponin a (SSa) is a compound extracted from a Chinese herb which has been widely used in treating liver diseases such as liver fibrosis. However, the mechanism of SSa in treatment of liver fibrosis still remain unclear. Our previous study demonstrated that BMP4 stimulated the expression of smooth muscle alpha actin (α-SMA) in the liver. Therefore, the current study investigates the effect of SSa on BMP4 expression during hepatic stellate cell activation in a human hepatic stellate cell line.

Methods: LX-2 cells were cultured in DMEM/F12 with fetal bovine serum and treated with SSa in different times and concentrations. The expression of BMP4 was examined by both RT-PCR and western blot analysis. WST-1 proliferation reagent was used to evaluate cell proliferation. α-SMA and Bax protein expression was determined by western blot analysis.

Results: Both mRNA and protein levels of BMP-4 were significantly inhibited in LX-2 cells after 5 μM SSa treatment. SSa significantly inhibited LX-2 proliferation at the concentration of 5μM while BMP-4 had no effect on LX-2 proliferation. BMP-4 increased α-SMA expression in LX-2 while SSa reduced α-SMA expression. In addition SSa could neutralize the effect of BMP-4 on α-SMA expression. SSd also inhibited BMP4 expression but not NG. Bax protein expression was induced in these cells by 5 μM SSa.

Conclusion: SSa could down-regulate BMP-4 expression and inhibit hepatic stellate cell activation. Therefore, SSa could be used for treatment of liver disease with elevated BMP-4 expression.

Keywords: ALK; BMP-4; Bone morphogenetic protein; Bupleurum chinense; CCl-4; DMEM/F12; Dulbecco's modified Eagle medium/F12; ECL; ECM; FBS; GDFs; HSCs; Hepatic fibrogenesis; Hepatic stellate cells; MAPKs; NG; RT-PCR; SDS; SSa; SSd; Saikosaponins and gene regulation; TBS; TGF-β; Tris-buffered-saline; activin receptor-like kinase; bone morphogenetic protein-4; carbon tetrachloride; enhanced chemiluminescence; extracellular matrix; fetal bovine serum; growth differentiation factors; hepatic stellate cells; mitogen-activated protein kinases; naringin; reverse transcriptase polymerase chain reaction; saikosaponin a; saikosaponin d; smooth muscle alpha actin; sodium dodecyl sulfate; transforming growth factor-β; α-SMA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism*
  • Animals
  • Bone Morphogenetic Protein 4 / genetics
  • Bone Morphogenetic Protein 4 / metabolism*
  • Bupleurum / chemistry*
  • Cattle
  • Cell Line
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Drugs, Chinese Herbal / pharmacology
  • Drugs, Chinese Herbal / therapeutic use
  • Hepatic Stellate Cells / drug effects*
  • Humans
  • Liver / cytology
  • Liver / drug effects*
  • Liver / metabolism
  • Liver Cirrhosis / drug therapy
  • Liver Cirrhosis / metabolism*
  • Oleanolic Acid / analogs & derivatives*
  • Oleanolic Acid / pharmacology
  • Oleanolic Acid / therapeutic use
  • Phytotherapy
  • RNA, Messenger / metabolism
  • Saponins / pharmacology*
  • Saponins / therapeutic use
  • bcl-2-Associated X Protein / metabolism

Substances

  • Actins
  • BMP4 protein, human
  • Bone Morphogenetic Protein 4
  • Drugs, Chinese Herbal
  • RNA, Messenger
  • Saponins
  • bcl-2-Associated X Protein
  • Oleanolic Acid
  • saikosaponin D